LIM/46 - Laboratório de Parasitologia Médica

O Laboratório de Parasitologia Médica é ligado ao Departamento de Moléstias Infecciosas e Parasitárias da Faculdade de Medicina da Universidade de São Paulo (FMUSP).

Linhas de pesquisa: parasitologia clínica (aplicada) envolvendo análises epidemiológicas, diagnóstico, tratamento (inclusive mediante uso de modelos experimentais) e prevenção; emprego de células-tronco no tratamento da miocardiopatia crônica da doença de Chagas e investigações sobre a Leishmaniose.

Site oficial: http://limhc.fm.usp.br/portal/lim46-laboratorio-de-parasitologia-medica/

Navegar

Novos documentos depositados

  1. Data-driven, cross-disciplinary collaboration: lessons learned at the largest academic health center in Latin America during the COVID-19 pandemic

    FRONTIERS IN PUBLIC HEALTH, v.12, article ID 1369129, 15p, 2024

    Introduction The COVID-19 pandemic has prompted global research efforts to reduce infection impact, highlighting the potential of cross-disciplinary collaboration to enhance research quality and efficiency.Methods At the FMUSP-HC academic health system, we implemented innovative flow management r...

  2. Thinking out of the box: revisiting health surveillance based on medical records

    ANTIMICROBIAL STEWARDSHIP AND HEALTHCARE EPIDEMIOLOGY, v.3, n.1, article ID e185, p, 2023

    Despite the considerable advances in the last years, the health information systems for health surveillance still need to overcome some critical issues so that epidemic detection can be performed in real time. For instance, despite the efforts of the Brazilian Ministry of Health (MoH) to make COV...

  3. Rapid viral metagenomics using SMART-9N amplification and nanopore sequencing

    WELLCOME OPEN RESEARCH, v.6, article ID 241, p, 2023

    Emerging and re-emerging viruses are a global health concern. Genome sequencing as an approach for monitoring circulating viruses is currently hampered by complex and expensive methods. Untargeted, metagenomic nanopore sequencing can provide genomic information to identify pathogens, prepare for ...

  4. Value of left ventricular longitudinal strain in predicting overt heart failure in patients with Chagas disease and preserved left ventricular ejection fraction

    EUROPEAN HEART JOURNAL, v.44, suppl.2, 2023

  5. Genetic variation in HLA genes: impact on transplant compatibility in a Brazilian admixed population

    HLA, v.101, n.4, p.361-361, 2023

  6. Exploring the prognostic significance and important phenotypic and genotypic associations of neural network-derived electrocardiographic features

    HEART, v.109, suppl.3, p.A96-A99, 2023

  7. Recognition of Trypanosoma cruzi epitopes by IgG of benznidazole treated Chagas disease patients

    BIOPHYSICAL REVIEWS, v.13, n.6, Special Issue, p.1432-1432, 2021

  8. Introduction, Dispersal, and Predominance of SARS-CoV-2 Delta Variant in Rio Grande do Sul, Brazil: A Retrospective Analysis

    MICROORGANISMS, v.11, n.12, article ID 2938, 18p, 2023

    Mutations in the SARS-CoV-2 genome can alter the virus' fitness, leading to the emergence of variants of concern (VOC). In Brazil, the Gamma variant dominated the pandemic in the first half of 2021, and from June onwards, the first cases of Delta infection were documented. Here, we investigate th...

  9. Nanobiotics and the One Health Approach: Boosting the Fight against Antimicrobial Resistance at the Nanoscale

    BIOMOLECULES, v.13, n.8, article ID 1182, 17p, 2023

    Antimicrobial resistance (AMR) is a growing public health concern worldwide, and it poses a significant threat to human, animal, and environmental health. The overuse and misuse of antibiotics have contributed significantly and others factors including gene mutation, bacteria living in biofilms, ...

  10. Estimated glomerular filtration rate in Brazilian adults with sickle cell disease: results from the REDS-III multicenter cohort study

    ANNALS OF HEMATOLOGY, v.102, n.5, p.1019-1027, 2023

    Chronic kidney disease (CKD) has a significant impact on sickle cell disease (SCD) morbidity and mortality. Early identification of individuals at highest risk of developing CKD may allow therapeutic intervention to prevent worse outcomes. This study aimed to evaluate the prevalence and risk fact...